Cargando…
Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients
OBJECTIVE: The capability of urinary TIMP-2 (tissue inhibitor of metalloproteinase) and IGFBP7 (insulin-like growth factor binding protein)—NephroCheck Test (NC) = ([TIMP-2] x [IGFBP7]) / 1000)—to predict renal recovery from acute kidney injury (AKI) has been poorly studied. The aim of this study wa...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234791/ https://www.ncbi.nlm.nih.gov/pubmed/28085896 http://dx.doi.org/10.1371/journal.pone.0169674 |
_version_ | 1782495051446747136 |
---|---|
author | Daubin, Delphine Cristol, Jean Paul Dupuy, Anne Marie Kuster, Nils Besnard, Noémie Platon, Laura Buzançais, Aurèle Brunot, Vincent Garnier, Fanny Jonquet, Olivier Klouche, Kada |
author_facet | Daubin, Delphine Cristol, Jean Paul Dupuy, Anne Marie Kuster, Nils Besnard, Noémie Platon, Laura Buzançais, Aurèle Brunot, Vincent Garnier, Fanny Jonquet, Olivier Klouche, Kada |
author_sort | Daubin, Delphine |
collection | PubMed |
description | OBJECTIVE: The capability of urinary TIMP-2 (tissue inhibitor of metalloproteinase) and IGFBP7 (insulin-like growth factor binding protein)—NephroCheck Test (NC) = ([TIMP-2] x [IGFBP7]) / 1000)—to predict renal recovery from acute kidney injury (AKI) has been poorly studied. The aim of this study was to assess the performance of measurements of ([TIMP-2] x [IGFBP7]) / 1000) over 24 hours to differentiate transient from persistent AKI. METHODS: Of 460 consecutive adult patients admitted to the ICU, 101 were prospectively studied: 56 men, 62 (52–71) years old. A fresh urine sample was collected at H(0), H(4), H(12) and H(24) to determine ([TIMP-2] x [IGFBP7]) / 1000) levels. Areas under the curves of Delta NC H(4)-H(o) and H(12)-H(4) and serum creatinine (sCr) for detection of AKI recovery were compared. RESULTS: Forty-one (40.6%) patient were diagnosed with AKI: 27 transient and 14 persistent AKI. At admission (H(0)), AKI patients had a significantly higher NC score than patients without AKI (0.43 [0.07–2.06] vs 0.15 [0.07–0.35], p = 0.027). In AKI groups, transient AKI have a higher NC, at H(0) and H(4), than persistent AKI (0.87 [0.09–2.82] vs 0.13 [0.05–0.66] p = 0.035 and 0.13 [0.07–0.61] vs 0.05 [0.02–0.13] p = 0.013). Thereafter, NC level decreased in both AKI groups with a Delta NC score H(4)-H(0) and H(12)-H(4) significantly more important in transient AKI. Roc curves showed however that delta NC scores did not discriminate between transient and persistent AKI. CONCLUSION: In our population, absolute urinary levels of NC score were higher at early hours after ICU admission (H(0) and H(4)) in transient AKI as compared to persistent AKI patients. NC variations (Delta NC scores) over the first 12 hours may indicate the AKI’s evolving nature with a more significant decrease in case of transient AKI but were not able to differentiate transient from persistent AKI. |
format | Online Article Text |
id | pubmed-5234791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-52347912017-02-06 Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients Daubin, Delphine Cristol, Jean Paul Dupuy, Anne Marie Kuster, Nils Besnard, Noémie Platon, Laura Buzançais, Aurèle Brunot, Vincent Garnier, Fanny Jonquet, Olivier Klouche, Kada PLoS One Research Article OBJECTIVE: The capability of urinary TIMP-2 (tissue inhibitor of metalloproteinase) and IGFBP7 (insulin-like growth factor binding protein)—NephroCheck Test (NC) = ([TIMP-2] x [IGFBP7]) / 1000)—to predict renal recovery from acute kidney injury (AKI) has been poorly studied. The aim of this study was to assess the performance of measurements of ([TIMP-2] x [IGFBP7]) / 1000) over 24 hours to differentiate transient from persistent AKI. METHODS: Of 460 consecutive adult patients admitted to the ICU, 101 were prospectively studied: 56 men, 62 (52–71) years old. A fresh urine sample was collected at H(0), H(4), H(12) and H(24) to determine ([TIMP-2] x [IGFBP7]) / 1000) levels. Areas under the curves of Delta NC H(4)-H(o) and H(12)-H(4) and serum creatinine (sCr) for detection of AKI recovery were compared. RESULTS: Forty-one (40.6%) patient were diagnosed with AKI: 27 transient and 14 persistent AKI. At admission (H(0)), AKI patients had a significantly higher NC score than patients without AKI (0.43 [0.07–2.06] vs 0.15 [0.07–0.35], p = 0.027). In AKI groups, transient AKI have a higher NC, at H(0) and H(4), than persistent AKI (0.87 [0.09–2.82] vs 0.13 [0.05–0.66] p = 0.035 and 0.13 [0.07–0.61] vs 0.05 [0.02–0.13] p = 0.013). Thereafter, NC level decreased in both AKI groups with a Delta NC score H(4)-H(0) and H(12)-H(4) significantly more important in transient AKI. Roc curves showed however that delta NC scores did not discriminate between transient and persistent AKI. CONCLUSION: In our population, absolute urinary levels of NC score were higher at early hours after ICU admission (H(0) and H(4)) in transient AKI as compared to persistent AKI patients. NC variations (Delta NC scores) over the first 12 hours may indicate the AKI’s evolving nature with a more significant decrease in case of transient AKI but were not able to differentiate transient from persistent AKI. Public Library of Science 2017-01-13 /pmc/articles/PMC5234791/ /pubmed/28085896 http://dx.doi.org/10.1371/journal.pone.0169674 Text en © 2017 Daubin et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Daubin, Delphine Cristol, Jean Paul Dupuy, Anne Marie Kuster, Nils Besnard, Noémie Platon, Laura Buzançais, Aurèle Brunot, Vincent Garnier, Fanny Jonquet, Olivier Klouche, Kada Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients |
title | Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients |
title_full | Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients |
title_fullStr | Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients |
title_full_unstemmed | Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients |
title_short | Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients |
title_sort | urinary biomarkers igfbp7 and timp-2 for the diagnostic assessment of transient and persistent acute kidney injury in critically ill patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234791/ https://www.ncbi.nlm.nih.gov/pubmed/28085896 http://dx.doi.org/10.1371/journal.pone.0169674 |
work_keys_str_mv | AT daubindelphine urinarybiomarkersigfbp7andtimp2forthediagnosticassessmentoftransientandpersistentacutekidneyinjuryincriticallyillpatients AT cristoljeanpaul urinarybiomarkersigfbp7andtimp2forthediagnosticassessmentoftransientandpersistentacutekidneyinjuryincriticallyillpatients AT dupuyannemarie urinarybiomarkersigfbp7andtimp2forthediagnosticassessmentoftransientandpersistentacutekidneyinjuryincriticallyillpatients AT kusternils urinarybiomarkersigfbp7andtimp2forthediagnosticassessmentoftransientandpersistentacutekidneyinjuryincriticallyillpatients AT besnardnoemie urinarybiomarkersigfbp7andtimp2forthediagnosticassessmentoftransientandpersistentacutekidneyinjuryincriticallyillpatients AT platonlaura urinarybiomarkersigfbp7andtimp2forthediagnosticassessmentoftransientandpersistentacutekidneyinjuryincriticallyillpatients AT buzancaisaurele urinarybiomarkersigfbp7andtimp2forthediagnosticassessmentoftransientandpersistentacutekidneyinjuryincriticallyillpatients AT brunotvincent urinarybiomarkersigfbp7andtimp2forthediagnosticassessmentoftransientandpersistentacutekidneyinjuryincriticallyillpatients AT garnierfanny urinarybiomarkersigfbp7andtimp2forthediagnosticassessmentoftransientandpersistentacutekidneyinjuryincriticallyillpatients AT jonquetolivier urinarybiomarkersigfbp7andtimp2forthediagnosticassessmentoftransientandpersistentacutekidneyinjuryincriticallyillpatients AT klouchekada urinarybiomarkersigfbp7andtimp2forthediagnosticassessmentoftransientandpersistentacutekidneyinjuryincriticallyillpatients |